TABLE 3.
Mean diameters of P. yoelii yoelii and P. falciparum schizonts in treated and untreated cultures
| Compound (μg/ml) | Mean diam (μm)± SD of schizonts in cultures for P. yoelii yoeliic | P value vs controld | Mean diam (μm) ± SD of schizonts in cultures for P. falciparumc | P value vs controld |
|---|---|---|---|---|
| Control | 25.7 ± 7.8 | 9.0 ± 3.1a/17.7 ± 9.1b | ||
| Grepafloxacin | ||||
| 3.125 | 12.4 ± 3.6 | <0.0001 | 4.1 ± 1.3a | <0.0001 |
| 6.25 | 8.3 ± 8.0 | <0.0001 | 3.6 ± 0.1a | <0.0001 |
| Trovafloxacin | ||||
| 12.5 | 12.9 ± 5.2 | <0.0001 | 3.7 ± 0.7a | <0.0001 |
| 25 | 9.7 ± 5.0 | <0.0001 | 3.9 ± 1.0a | <0.0001 |
| Piromidic acid | ||||
| 25 | 9.4 ± 3.8 | <0.0001 | 14.4 ± 3.5b | 0.09 |
| 50 | 4.3 ± 1.4 | <0.0001 | 6.3 ± 1.6b | <0.0001 |
Assessment of in vitro activity at 72 h.
Activity evaluated at 120 h.
Measurements of 25 schizonts were performed using an immunofluorescence test with an anti-HSPi72 antibody (magnification, ×250).
Student t test; significant for P < 0.05.